Overall Survival Benefit of Radium-223 Chloride (Alpharadin™) in the Treatment of Patients with Symptomatic Bone Metastases in Castration-resistant Prostate Cancer (CRPC): a Phase III Randomized Trial (ALSYMPCA)
Year: 2011
Type: article
Source: European Journal of Cancer
Authors: C. Parker, D. Heinrich, J.M. O'Sullivan, S. Fossa, A. Chodacki, T. Demkow, A. Cross, B. Bolstad, J. Garcia-Vargas, O. Sartor
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2139232028